RecruitingNCT06761261

Acute Hepatitis in Pediatrics

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

437 participants

Start Date

Oct 16, 2023

Study Type

OBSERVATIONAL

Conditions

Hepatitis

Summary

This study aims to investigate wich symptoms and blood test characteristics acute hepatitis manifests in pediatric age. The study will be conducted because acute hepatitis is not an easily and clearly recognized disease in children. This study aims to better characterize this disease by describing the frequency of the different symptoms with which it can manifest and the changes it causes in blood tests. It also aims to assess the occurrence of any complications of pediatric acute hepatitis. The study is observational, so it is limited to collecting data and analyzing the patient's clinical course without interfering with normal clinical practice.

Eligibility

Max Age: 17 Years

Inclusion Criteria3

Age between 0 and 17 years (extremes included).
Access to PSP and/or hospitalized (OBI or hospitalization)
Diagnosis of acute hepatitis

Exclusion Criteria3

Refusal of the parent/guardian to participate in the study.
Mild hypertransaminasemia (\<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).
Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.